A drink to cure liver disease

NasVax, an Israeli company based in Ness-Ziona, has developed an oral treatment for people suffering from Nonalcoholic steatohepatitis (NASH) commonly known as “fatty liver disease” which affects up to 15 million US citizens. It is undergoing trials and also conversion into a pill.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *